129 related articles for article (PubMed ID: 11058411)
1. Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080.
Ball AJ; Flatt PR; McClenaghan NH
Pharmacol Res; 2000 Dec; 42(6):575-9. PubMed ID: 11058411
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
[TBL] [Abstract][Full Text] [Related]
3. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
Gao H; Mourtada M; Morgan NG
JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
[TBL] [Abstract][Full Text] [Related]
4. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
Bleck C; Wienbergen A; Rustenbeck I
Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
[TBL] [Abstract][Full Text] [Related]
5. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
6. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
7. Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.
McClenaghan NH; Ball AJ; Flatt PR
Biochem Pharmacol; 2001 Mar; 61(5):527-36. PubMed ID: 11239495
[TBL] [Abstract][Full Text] [Related]
8. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
Chan SL; Atlas D; James RF; Morgan NG
Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Biochem Biophys Res Commun; 2000 Apr; 271(1):234-9. PubMed ID: 10777708
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
Chan SL; Mourtada M; Morgan NG
Diabetes; 2001 Feb; 50(2):340-7. PubMed ID: 11272145
[TBL] [Abstract][Full Text] [Related]
11. Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide.
McClenaghan NH; Ball AJ; Flatt PR
Br J Pharmacol; 2000 May; 130(2):478-84. PubMed ID: 10807689
[TBL] [Abstract][Full Text] [Related]
12. Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse.
Mayer G; Taberner PV
Eur J Pharmacol; 2002 Nov; 454(1):95-102. PubMed ID: 12409010
[TBL] [Abstract][Full Text] [Related]
13. Identification of morin as an agonist of imidazoline I-3 receptor for insulin secretion in diabetic rats.
Lin MH; Hsu CC; Lin J; Cheng JT; Wu MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):997-1003. PubMed ID: 28689255
[TBL] [Abstract][Full Text] [Related]
14. Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.
Chan SL
Gen Pharmacol; 1998 Oct; 31(4):525-9. PubMed ID: 9792210
[TBL] [Abstract][Full Text] [Related]
15. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.
Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G
Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667
[TBL] [Abstract][Full Text] [Related]
16. Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets.
Mourtada M; Chan SL; Smith SA; Morgan NG
Br J Pharmacol; 1999 Jul; 127(5):1279-87. PubMed ID: 10455276
[TBL] [Abstract][Full Text] [Related]
17. Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans.
Cooper EJ; Hudson AL; Parker CA; Morgan NG
Eur J Pharmacol; 2003 Dec; 482(1-3):189-96. PubMed ID: 14660022
[TBL] [Abstract][Full Text] [Related]
18. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors.
Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG
Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]